Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Total Liabilities (2023 - 2025)

Camp4 Therapeutics (CAMP) has disclosed Total Liabilities for 3 consecutive years, with $70.1 million as the latest value for Q4 2025.

  • Quarterly Total Liabilities rose 362.34% to $70.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $70.1 million through Dec 2025, up 362.34% year-over-year, with the annual reading at $70.1 million for FY2025, 362.34% up from the prior year.
  • Total Liabilities hit $70.1 million in Q4 2025 for Camp4 Therapeutics, up from $27.7 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $147.1 million in Q2 2024 to a low of $11.2 million in Q1 2025.
  • Historically, Total Liabilities has averaged $56.4 million across 3 years, with a median of $23.0 million in 2024.
  • Biggest YoY gain for Total Liabilities was 362.34% in 2025; the steepest drop was 92.33% in 2025.
  • Year by year, Total Liabilities stood at $16.5 million in 2023, then decreased by 8.26% to $15.2 million in 2024, then surged by 362.34% to $70.1 million in 2025.
  • Business Quant data shows Total Liabilities for CAMP at $70.1 million in Q4 2025, $27.7 million in Q3 2025, and $11.3 million in Q2 2025.